(b)Percent of Class: 5.5% based on 30,802,114 shares of common stock outstanding as of March 31, 2015
DELRAY BEACH, Fla., April 13, 2015 (GLOBE NEWSWIRE) -- VeriTeQ Corporation ("VeriTeQ") (OTC Markets:VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has expanded its intellectual property portfolio with a patent filing in Brazil for its high-temperature Q Inside Safety Technology micro-transponder.
VeriTeQ would exclusively license its intellectual property, safety data test and FDA file reference, and business opportunities related to its Q Inside Safety Technology for the breast implant market to EL, and EL would pay an upfront license fee of $1.75 million. EL would also have a 24-month option to purchase VeriTeQ's Q Inside Safety Technology business for the breast implant market for $10 million
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.